Bone mineral density in patients with nonalcoholic steatohepatitis among end-stage liver disease patients awaiting liver transplantation

Endocrine Practice

Volumn 19, Issue 3, 2013, Pages 414-419

  Boonchaya Anant, Patchaya ^a   Hardy, Elvin ^a   Borg, Brian B ^a   Burshell, Alan L ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; END STAGE LIVER DISEASE; FEMALE; FEMUR NECK; HEPATITIS B; HEPATITIS C; HIP; HUMAN; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONALCOHOLIC FATTY LIVER; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; BONE DENSITY; FATTY LIVER; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84880083609     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12319.OR     Document Type: Article

References (31)

1. Bonkovsky HL, Hawkins M, Steinberg K, et al. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology. 1990;12:273-380.
2. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 1990;31:82-87.
3. Carey EJ, Balan V, Kremers WK, Hay JE. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl. 2003;9:1166-1173.
4. Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl. 2004;10:648-653.
5. Monegal A, Navasa M, Gua'abens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148-154.
6. Mahmoudi A, Sellier N, Reboul-Marty J, et al. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study. Clin Res Hepatol Gastroenterol. 2011;35:731-737.
7. Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:660-670.
8. Collier J. Bone disorders in chronic liver disease. Hepatology. 2007;46:1271-1278.
9. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28:339-350.
10. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11:1-16, vii.
11. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association wit. The insulin resistance syndrome. Hepatology. 2002;35:373-379.
12. Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms o. The pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16:2223-2226.
13. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone Dissectin. The diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005;289:E735-E745.
14. Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H. Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med. 2000; 17:124-129.
15. Stolk RP, Van Daele PL, Pols HA, et al. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone. 1996;18:545-549.
16. Wibaux C, Legroux-Gerot I, Dharancy S, et al. Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine. 2011;78:387-391.
17. Loria I, Albanese C, Giusto M, et al. Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc. 2010;42:1191-1193.
18. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int. 2001;69:321-326.
19. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women. The Framingham study. J Bone Miner Res. 1993;8:567-573.
20. Angelico F, Del Ben M, Conti R, et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol. 2003;18:588-594.
21. Angelico F, Del Ben M, Conti R, et al. Insulin resistance. The metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2005;90:1578-1582.
22. Clemens TL, Karsenty G. The osteoblast: An insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011;26:677-680.
23. Yano H, Ohya K, Amagasa T. Effects of insulin on in vitro bone formation in fetal rat parietal bone. Endocr J. 1994; 41:293-300.
24. Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DI, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women fro. The Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance Diabetologia. 2004;47:1963-1968.
25. de Liefde, II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus. The Rotterdam Study. Osteoporos Int. 2005;16:1713-1720.
26. Gupta R, Mohammed AM, Mojiminiyi OA, Alenizi EK, Abdulla NA. Bone mineral density in premenopausal Arab women with type 2 diabetes mellitus. J Clin Densitom. 2009;12:54-57.
27. Koroglu BK, Kiris F, Ersoy IH, et al. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynol Pol. 2011;62:429-435.
28. Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248-254.
29. Pirgon O, Bilgin H, Tolu I, Odabas D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2011;75:189-195.
30. Luxon BA. Bone disorders in chronic liver diseases. Curr Gastroenterol Rep. 2011;13:40-48.
31. Targher G, Bertolini L, Rodella S, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring). 2008;16:1394-1399.